CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 2.86 Million AUD | -4.17% |
| 2023 | 2.99 Million AUD | -20.13% |
| 2022 | 3.74 Million AUD | -18.78% |
| 2021 | 4.6 Million AUD | 156.11% |
| 2020 | 1.8 Million AUD | 116.97% |
| 2019 | 829.61 Thousand AUD | 21.45% |
| 2018 | 683.1 Thousand AUD | -23.22% |
| 2017 | 889.69 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.94 Million AUD | 5.49% |
| 2024 Q4 | 2.86 Million AUD | 0.0% |
| 2024 FY | 2.86 Million AUD | -4.17% |
| 2024 Q3 | 2.86 Million AUD | -27.45% |
| 2024 Q2 | 3.94 Million AUD | 0.0% |
| 2023 Q4 | 3.74 Million AUD | 25.21% |
| 2023 Q2 | 3.43 Million AUD | 0.0% |
| 2023 FY | 2.99 Million AUD | -20.13% |
| 2023 Q1 | 3.43 Million AUD | -8.32% |
| 2023 Q3 | 2.99 Million AUD | -12.89% |
| 2022 Q4 | 3.74 Million AUD | 0.0% |
| 2022 Q3 | 3.74 Million AUD | -14.97% |
| 2022 Q2 | 4.4 Million AUD | 0.0% |
| 2022 Q1 | 4.4 Million AUD | -4.49% |
| 2022 FY | 3.74 Million AUD | -18.78% |
| 2021 Q1 | 4.81 Million AUD | 162.36% |
| 2021 FY | 4.6 Million AUD | 156.11% |
| 2021 Q2 | 4.81 Million AUD | 0.0% |
| 2021 Q4 | 4.6 Million AUD | 0.0% |
| 2021 Q3 | 4.6 Million AUD | -4.18% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 1.83 Million AUD | 0.0% |
| 2020 Q4 | 1.83 Million AUD | 0.0% |
| 2020 FY | 1.8 Million AUD | 116.97% |
| 2019 FY | 829.61 Thousand AUD | 21.45% |
| 2018 FY | 683.1 Thousand AUD | -23.22% |
| 2017 FY | 889.69 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| 4DMedical Limited | 992.24 Thousand AUD | -188.788% |
| Adherium Limited | 1.58 Million AUD | -81.097% |
| Aroa Biosurgery Limited | 7.43 Million AUD | 61.434% |
| Atomo Diagnostics Limited | 1.83 Million AUD | -55.839% |
| Anteris Technologies Ltd | 646.71 Thousand AUD | -343.086% |
| Control Bionics Limited | 404.15 Thousand AUD | -609.017% |
| CardieX Limited | 2.55 Million AUD | -12.218% |
| Compumedics Limited | 13.21 Million AUD | 78.31% |
| Cochlear Limited | 391.6 Million AUD | 99.268% |
| Cyclopharm Limited | 10.12 Million AUD | 71.69% |
| EMVision Medical Devices Ltd | - AUD | -Infinity% |
| Nova Eye Medical Limited | 4.28 Million AUD | 33.096% |
| HeraMED Limited | 361.61 Thousand AUD | -692.422% |
| Imricor Medical Systems, Inc. | 2.46 Million AUD | -16.291% |
| ImpediMed Limited | 759 Thousand AUD | -277.535% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.61 Million AUD | -77.101% |
| Micro-X Limited | 5.37 Million AUD | 46.728% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 391.67 Thousand AUD | -631.607% |
| PolyNovo Limited | 8.97 Million AUD | 68.062% |
| Respiri Limited | 2.75 Million AUD | -4.141% |
| SomnoMed Limited | 6.28 Million AUD | 54.41% |
| Universal Biosensors, Inc. | 4.37 Million AUD | 34.547% |
| Uscom Limited | 623.62 Thousand AUD | -359.489% |
| Visioneering Technologies, Inc. | 3.16 Million AUD | 9.52% |